Nader Pouratian

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Nader Pouratian sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials 3 currently recruiting upper quartile by trial count

Nader Pouratian: 3 sponsored US clinical trials, 3 recruiting.

Nader Pouratian sponsors 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. The most-studied condition in this pipeline is Undergoing Deep Brain Stimulation (DBS) Surgery, with 1 trials.

Upper-quartile sponsor footprint

Nader Pouratian sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Nader Pouratian pipeline

3 recruiting of 3 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Undergoing Deep Brain Stimulation (DBS) Surgery (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Nader Pouratian: open-pipeline peers nationwide

Peers matched on 3 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Nader Pouratian sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1.522.533.544.5 0%50%100%150% Total trials Recruiting share Nader Pouratian10xBio22nd Century GroupAA SecordAAADRS Clinical Research CenterAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Nader Pouratian sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Nader Pouratian sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

What to do with this Nader Pouratian page

3 registered trials is a research-attention snapshot, not an endorsement of Nader Pouratian or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Nader Pouratian pipeline card: 3 registered trials from official public datasets.Report a data error.